112 related articles for article (PubMed ID: 30834969)
1. Patients' perspectives towards malignant ascites: results of a prospective observational trial regarding expectations, characteristics and quality of life-a study of the North-Eastern-German Society of Gynecological Oncology.
Armbrust R; Neeb C; Thuss-Patience P; Lüftner D; Pietzner K; Riess H; Oskay-Öczelik G; Richter R; Keller M; Sehouli J
Arch Gynecol Obstet; 2019 May; 299(5):1385-1389. PubMed ID: 30834969
[TBL] [Abstract][Full Text] [Related]
2. A survey of treatment approaches of malignant ascites in Germany and Austria.
Jehn CF; Küpferling S; Oskay-Özcelik G; Lüftner D
Support Care Cancer; 2015 Jul; 23(7):2073-8. PubMed ID: 25528551
[TBL] [Abstract][Full Text] [Related]
3. Continuous low flow ascites drainage through the urinary bladder via the Alfapump system in palliative patients with malignant ascites.
Fotopoulou C; Berg T; Hausen A; Hennig R; Jalan R; Malagó M; Capel J; De Gottardi A; Stirnimann G
BMC Palliat Care; 2019 Dec; 18(1):109. PubMed ID: 31805921
[TBL] [Abstract][Full Text] [Related]
4. Preoperative quality of life as prediction for severe postoperative complications in gynecological cancer surgery: results of a prospective study.
Sehouli J; Heise K; Richter R; Woopen H; Anders L; Inci MG
Arch Gynecol Obstet; 2021 Apr; 303(4):1057-1063. PubMed ID: 33119788
[TBL] [Abstract][Full Text] [Related]
5. Quantum dot-based multiplexed imaging in malignant ascites: a new model for malignant ascites classification.
Zeng WJ; Peng CW; Yuan JP; Cui R; Li Y
Int J Nanomedicine; 2015; 10():1759-68. PubMed ID: 25784803
[TBL] [Abstract][Full Text] [Related]
6. Outpatient Intraperitoneal Catumaxomab Therapy for Malignant Ascites Related to Advanced Gynecologic Neoplasms.
Kurbacher CM; Horn O; Kurbacher JA; Herz S; Kurbacher AT; Hildenbrand R; Bollmann R
Oncologist; 2015 Nov; 20(11):1333-41. PubMed ID: 26417039
[TBL] [Abstract][Full Text] [Related]
7. Malignant ascites symptom cluster in patients referred for paracentesis.
Husain A; Bezjak A; Easson A
Ann Surg Oncol; 2010 Feb; 17(2):461-9. PubMed ID: 19866240
[TBL] [Abstract][Full Text] [Related]
8. The role of "closed abdomen" hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience.
Orgiano L; Pani F; Astara G; Madeddu C; Marini S; Manca A; Mantovani G
Support Care Cancer; 2016 Oct; 24(10):4293-9. PubMed ID: 27169699
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
10. Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy.
Ben-Arye E; Samuels N; Schiff E; Raz OG; Sharabi IS; Lavie O
Support Care Cancer; 2015 Dec; 23(12):3411-9. PubMed ID: 25752885
[TBL] [Abstract][Full Text] [Related]
11. Impact of Body Mass Index (BMI) on Chemotherapy-associated Toxicity in Ovarian Cancer Patients. A Pooled Analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO) Databank on 1,213 Patients.
Grabowski JP; Richter R; Rittmeister H; Chekerov R; Woopen H; Sehouli J
Anticancer Res; 2018 Oct; 38(10):5853-5858. PubMed ID: 30275210
[TBL] [Abstract][Full Text] [Related]
12. Malignant Ascites: Validation of a Novel Ascites Symptom Mini-Scale for Use in Patients With Ovarian Cancer.
Eitan R; Raban O; Tsoref D; Jakobson-Setton A; Sabah G; Salman L; Yeoshua E; Ben-Haroush A
Int J Gynecol Cancer; 2018 Jul; 28(6):1162-1166. PubMed ID: 29664840
[TBL] [Abstract][Full Text] [Related]
13. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites.
Easson AM; Bezjak A; Ross S; Wright JG
Ann Surg Oncol; 2007 Aug; 14(8):2348-57. PubMed ID: 17505860
[TBL] [Abstract][Full Text] [Related]
14. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
Busolo D; Woodgate R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
[TBL] [Abstract][Full Text] [Related]
15. Providing integrative care in the pre-chemotherapy setting: a pragmatic controlled patient-centered trial with implications for supportive cancer care.
Ben-Arye E; Dahly H; Keshet Y; Dagash J; Samuels N
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1825-1833. PubMed ID: 29980837
[TBL] [Abstract][Full Text] [Related]
16. Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.
King MT; Stockler MR; O'Connell RL; Buizen L; Joly F; Lanceley A; Hilpert F; Okamoto A; Aotani E; Bryce J; Donnellan P; Oza A; Avall-Lundqvist E; Berek JS; Sehouli J; Feeney A; Berton-Rigaud D; Costa DSJ; Friedlander ML;
Qual Life Res; 2018 Jan; 27(1):59-74. PubMed ID: 29248998
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer with malignant ascites: clinical features and outcomes.
Takahara N; Isayama H; Nakai Y; Sasaki T; Saito K; Hamada T; Mizuno S; Miyabayashi K; Mohri D; Kogure H; Matsubara S; Yamamoto N; Hirano K; Ijichi H; Tateishi K; Tada M; Koike K
Pancreas; 2015 Apr; 44(3):380-5. PubMed ID: 25636085
[TBL] [Abstract][Full Text] [Related]
18. Unmet needs for information and psychosocial support in relation to quality of life and emotional distress: A comparison between gynecological and breast cancer patients.
Faller H; Brähler E; Härter M; Keller M; Schulz H; Wegscheider K; Weis J; Boehncke A; Reuter K; Richard M; Sehner S; Koch U; Mehnert A
Patient Educ Couns; 2017 Oct; 100(10):1934-1942. PubMed ID: 28592366
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in gynecological inpatients undergoing surgery.
Matsushita T; Murata H; Matsushima E; Sakata Y; Miyasaka N; Aso T
Health Care Women Int; 2007 Oct; 28(9):828-42. PubMed ID: 17907010
[TBL] [Abstract][Full Text] [Related]
20. Health utilities in gynecological oncology and mastology in Germany.
Hildebrandt T; Thiel FC; Fasching PA; Graf C; Bani MR; Loehberg CR; Schrauder MG; Jud SM; Hack CC; Beckmann MW; Lux MP
Anticancer Res; 2014 Feb; 34(2):829-35. PubMed ID: 24511019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
